Every S-1 that MITESCO INC (MITI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-1 covers the registration statement a company files to sell shares publicly, so if you follow MITI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MITI filings page.
Mitesco, Inc. is registering for resale up to 106,548,245 shares of common stock by existing stockholders, with no shares sold by the company and no proceeds to it. The registered shares include 2,628,179 shares issued for cancellation of approximately $12.4 million of obligations, up to 86,262,000 shares underlying the mandatory redemption of Series A Amortizing Convertible Preferred Stock, 2,762,233 previously issued shares, and shares issuable upon conversion of 2025 and 2026 Bridge Notes.
Common stock outstanding was 20,940,597 shares as of June 30, 2026, and could rise to 127,488,842 shares if all Series A redemptions and Bridge Note conversions occur. Mitesco now operates as a holding company through Centcore (data center and cloud services) and Vero Technology Ventures (AI and cloud applications, including the planned “Robo Agent” product). Management has restructured about $26 million of legacy clinic-related obligations into common and Series A Preferred stock and issued multiple 10% Original Issue Discount Convertible Promissory Notes secured by all assets, generally convertible at $0.15 per share or a market-based discount.
As of March 31, 2026, Mitesco reported cash of approximately $1,500 and current liabilities of about $19.5 million, and its auditors and management note substantial doubt about its ability to continue as a going concern. The company highlights risks including potential severe dilution from Series A Preferred redemptions (up to 86,262,000 shares, described as over 90% dilution), reliance on additional capital, significant settlement and judgment obligations, cybersecurity threats, and extensive regulatory, financial, and competitive uncertainties.
Mitesco, Inc. is registering 106,548,245 shares of common stock for resale by existing securityholders, and will not receive proceeds from these sales. The shares include stock issued or issuable from debt restructuring, Series A Preferred redemptions and conversions of 2025–2026 Bridge Notes.
Only resale stockholders are selling; 20,940,597 shares were outstanding as of June 30, 2026. The filing details a major restructuring of over $30 million of historical obligations, substantial potential dilution from Series A Preferred redemptions, significant secured bridge financing, and a going concern warning due to losses and limited liquidity.
Mitesco, Inc. has filed a Form S-1 registering up to 106,836,091 shares of common stock for resale by existing investors, with the company itself not selling any securities and receiving no proceeds from these sales.
The shares include stock issued or issuable from a large debt restructuring, notably up to 97,779,013 shares tied to the redemption of Series A Preferred Stock and 3,666,666 shares from potential conversion of 2025 bridge notes. Mitesco had 15,093,055 shares outstanding as of December 29, 2025, and projects up to 115,524,531 shares outstanding if all Series A redemptions and bridge note conversions occur, implying substantial potential dilution. The filing also discloses a history of losses, heavy legacy obligations, and an auditor-raised substantial doubt about its ability to continue as a going concern absent new capital and meaningful revenue growth.
Mitesco, Inc. is registering up to 105,002,758 shares of common stock for resale by existing stockholders. The company itself is not selling securities and will receive no proceeds from these sales. The registered shares include stock issued and issuable in a large debt restructuring, shares underlying Series A Amortizing Convertible Preferred Stock, previously issued common shares, and shares related to a 2025 convertible bridge note.
Mitesco has shifted from a discontinued clinic business to a holding-company model focused on data center services through Centcore and cloud and AI software ventures through Vero Technology Ventures. As of December 4, 2025, 15,093,055 common shares were outstanding, with total shares potentially reaching 113,691,198 if Series A Preferred redemptions and the bridge note conversion occur. The company reports substantial doubt about its ability to continue as a going concern, with minimal cash, significant liabilities, and a need for additional capital.
The filing highlights extensive risks, including severe potential dilution from Series A Preferred redemptions, settlement obligations from prior clinic leases and vendors, thin and volatile trading in its stock, cybersecurity threats, intense competition in data services, evolving regulatory requirements, and execution risk around its acquisition and growth strategy.